The supply of Pralidoxime Chloride 2026
key details
| Value | £1 |
|---|---|
| Status | planning |
| Category (CPV) | 33600000 |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-06e4cd |
description
UKHSA is inviting suppliers to participate in a preliminary market engagement exercise for Pralidoxime Chloride through this Request for Information (RFI), in accordance with the Procurement Act 2023.
Suppliers wishing to be considered for inclusion in this procurement exercise must confirm their participation by the stated deadline. Suppliers who do not participate will not be included in the procurement process or considered for subsequent stages.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 14 Aug 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 077753-2026 |
more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Vaccine Prospectus: National Immunisation Programme and vaccine products · 8 Sept 2026
- ICP-MS Trade in and upgrade · £91,500 · 8 Sept 2026
- 3 x Cryogenic Freezers (Culture Collections) · £76,484 · 8 Sept 2026
- 3 x Myra9 Liquid handler for Molecular workflows · £97,043 · 8 Sept 2026
- Media Buying Services contract · £333,330 · 3 Sept 2026
- Purchase of IR Instrumentation for Upgrade of GammeTracers · £112,490 · 3 Sept 2026
- Health Security Campus: Senior Construction Advisory · £91,000 · 28 Aug 2026
- Engineering Inspection Services 26/27 · £46,662 · 28 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.